Filter announcements
Loading...
Saroja Pharma Industries India is engaged in amongst the leading traders, exporter and suppliers of Specialty Chemicals. The offered range is widely praised for its superior effectiveness, shelf life and perfect composition
Saroja Pharma reports strong FY25, with revenue climbing to ₹53.73 Cr and PAT reaching ₹1.03 Cr. Shareholders will consider appointing Ms. Anita Sethia as Independent Director. Auditors noted issues verifying accounting software's audit trail. No dividend was declared.